Table 2.
MMP inhibition potencies and clogD (logD) values of lead structures and target novel hydroxamic acids
| IC50 [nM]a | log D values | ||||||
|---|---|---|---|---|---|---|---|
| Compound | R | X | MMP-2 | MMP-9 | clogDb | logD (exp.) | Ref. |
| (R)-CGS 27023A | CH3 | N | 20c | 8c | 1.49 | (Mac Pherson et al., 1997) | |
| (R)-CGS 25966 | CH3 | CH | 11c | 27c | 2.72 | (Scozzafava and Supuran, 2000) | |
| (R)-FEtO- CGS 25966 | CH2CH2F | CH | 4 ± 3 | 50 ± 27 | 2.92 | 2.02 ± 0.03 | (Wagner et al., 2011) |
| (R)-2 | CH3 | N | 9.3 ± 2.0 | 8.3 ± 0.1 | 0.81 | (Behrends et al., 2015) | |
| (S)-2 | CH3 | N | 7.2 ± 0.1 | 4.9 ± 0.4 | 0.81 | (Behrends et al., 2015) | |
| (R)-9a | CH2CH2F | CH | 10.4 ± 5.9 | 0.5 ± 0.3 | 2.23 | ||
| (S)-9a | CH2CH2F | CH | 0.3 ± 0.03 | 0.1 ± 0.01 | 2.23 | 1.16 ± 0.2d | |
aStandard deviations based on three independent experiments are given for IC50 values in nM range
bclogD values were calculated by ChemAxon LogD predictor, (logD = logP at physiological pH 7.4)
cKi values, where SDs are not denoted
dlogD value was determined for compound (S)-[18F]9a